| Document |
Document Title |
|
WO/2024/040182A1 |
Disclosed herein is the use of purified 2-S rimantadine or purified 2-R rimantadine or a pharmaceutically acceptable thereof to treat cancers and precancer lesions, including cancers and precancer lesions associated with papilloma virus ...
|
|
WO/2024/039119A1 |
The present invention provides: a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electric element using same; and an electronic device thereof.
|
|
WO/2024/033786A1 |
Methods for the purification of impure triethylenetetramine into highly pure triethylenetetramine are described. In particular, methods for the preparation of relatively pure salts of triethylenetetramine starting from crude triethylenet...
|
|
WO/2024/034659A1 |
Provided are an organic electroluminescent element having further improved element performance and an electronic appliance including such organic electroluminescent element. Specifically, provided are a compound represented by formula (1...
|
|
WO/2024/029524A1 |
A fluorine-containing aromatic compound such as perfluorotoluene can be produced efficiently by reacting a compound represented by general formula (2) (In the formula, n is the same as above. X3 are the same or different and represent a ...
|
|
WO/2024/030736A1 |
Processes and facilities for producing several types of recycled content organic chemical compounds from waste plastic. Processing schemes are described herein for converting waste plastic (or hydrocarbon having recycled content derived ...
|
|
WO/2024/020765A1 |
Disclosed in the present invention is a synthesis method for an arylamine compound containing a bis-substituted indolone skeleton. The synthesis method comprises the following steps: using 3-pyrrolyloxindole and vinyl benzoxazinone as re...
|
|
WO/2024/025869A1 |
The present invention provides modified triarylmethane dyes comprising the structure shown in Formula 3, wherein R1, R2, R3, R4, R5, R6, R7, A1, A2, A1', and A2' are defined herein.
|
|
WO/2022/224741A9 |
[Problem] In hydrogenating an aromatic halonitro compound, to improve the yield of a halogenated aromatic amine that is the target product without requiring a dehalogenation inhibitor, while suppressing the formation of a nitroso compoun...
|
|
WO/2024/023845A1 |
Aspects of the present application relates to amorphous solid dispersions of evocalcet with polymer matrix, formic acid salt of evocalcet and process for the preparation of evocalcet.
|
|
WO/2024/022170A1 |
A functional layer material, comprising a compound formed by using a sp3-hybridized carbon atom as a center. The compound formed by using the sp3-hybridized carbon atom as the center comprises a first type of compound. The first type of ...
|
|
WO/2024/021264A1 |
The present invention relates to an organic electroluminescent device, an organic electroluminescent apparatus and a photoelectric device, and belongs to the technical field of organic electroluminescent apparatuses. The organic electrol...
|
|
WO/2024/024591A1 |
Provided are: a compound and a material for an organic electroluminescent element that further improve the performance of organic EL elements; an organic electroluminescent element having improved element performance; and an electronic d...
|
|
WO/2024/021969A1 |
The present invention provides a method for controlling aniline impurities that are difficult to treat in waste brine in a DAM production process, the method comprising the following steps: (1) in the presence of an iron-molybdenum catal...
|
|
WO/2024/018394A1 |
The present invention relates to a process for the preparation of crystalline form A of N, N'-bis(2-aminoethyl)-1,2-ethanediamine tetrahydrochloride (I).
|
|
WO/2024/016317A1 |
Provided is a compound, having a structure of formula (I), wherein substituents are as defined in the description. In addition, the present application further provides a preparation method for and a use of the compound of formula (I), a...
|
|
WO/2024/018965A1 |
[Problem] To suppress any reduction in the selectivity of halogenated aromatic amines of a target product caused by a halogen separation reaction in hydrogenation of an aromatic halonitro compound. [Solution] A hydrogenation catalyst tha...
|
|
WO/2024/011414A1 |
Disclosed in the present invention is a reaction method for secondary amine and o-diiodobenzene, comprising: reacting secondary amine with o-diiodobenzene in the presence of an alkali metal hydride or a Grignard reagent to complete the r...
|
|
WO/2024/011559A1 |
Disclosed is a process for preparing fused aromatic amine from isocyanide and cyclopropene.
|
|
WO/2024/014325A1 |
An aromatic compound configured from a stable isotope, wherein two adjacent carbon atoms are 13C, the nuclear spin quantum number of the other atoms to which the two adjacent carbon atoms bond is 0, and a hydrogen atom that has a spin co...
|
|
WO/2024/008728A1 |
The present invention relates to a solvent-efficient process for recycling one or more polymers selected from the group consisting of polyurethanes, polyurethane ureas, polyisocyanurates, and a mixture of two or more thereof, said one or...
|
|
WO/2024/010732A1 |
Small molecule inhibitors of the glutamine transporter ASCT2 and methods for their use are provided herein. The ASCT2 inhibitors described herein are useful in treating and/or preventing conditions or diseases associated with ASCT2-media...
|
|
WO/2024/007903A1 |
The present invention belongs to the field of agricultural fungicides and bactericide, and specifically relates to an N-substituted aniline compound, and the uses thereof as a bactericide and a fungicide. The N-substituted aniline compou...
|
|
WO/2024/011239A1 |
Provided herein are substituted quaternary amine salt compounds and compositions thereof for inhibiting production of trimethylamine (TMA), as well as inhibiting the conversion of choline to trimethylamine, and such compounds, and compos...
|
|
WO/2024/008727A1 |
The present invention relates to a process for recycling one or more polymers selected from the group consisting of polyurethanes, polyurethane ureas, polyisocyanurates, and a mixture of two or more thereof, said one or more polymers bei...
|
|
WO/2024/002748A1 |
This invention relates to a method for the manufacture of ethyleneamine from a mixture comprising water (H2O), ethylenediamine (EDA) and N-methylethylendiamine (NMEDA), comprising the steps of: (i) providing a feed stream comprising EDA,...
|
|
WO/2024/002740A1 |
The present invention relates to a method for the manufacture of ethyleneamine from a mixture comprising water (H2O), ethylenediamine (EDA) and N-methylethylendiamine (NMEDA), comprising the steps of: (i) providing a feed stream comprisi...
|
|
WO/2024/002975A1 |
The invention relates to a method of recovery of the monomers from a polyamide (PA) of the AABB type comprising the following steps: - a) a product (P) comprising the polyamide (PA) is optionally comminuted; - b) an aqueous medium compri...
|
|
WO/2023/249027A1 |
A quaternary ammonium salt that has a specific structure, an organic structure-directing agent that contains this quaternary ammonium salt, and a method for producing a quaternary ammonium salt. Also, a CON-type zeolite that is mixed cry...
|
|
WO/2023/247781A1 |
The present invention relates to short peptides or salts thereof which can be modified with appropriate hydrophobic tails to generate amphiphilic molecules useful for the intracellular delivery of molecules of biological interest. Thus, ...
|
|
WO/2023/249374A1 |
Disclosed are an apparatus and a method for producing perfluoro tripropylamine (PFTPA) by using electrochemical fluorination. The production method according to an embodiment is a method for producing PFTPA by forced convection of a mixe...
|
|
WO/2023/249377A1 |
A perfluorotripropylamine (PFTPA) preparation apparatus and method using electrochemical fluorination (ECF) are disclosed. The preparation method according to one embodiment comprises: a preparation step of preparing PFTAA from a mixture...
|
|
WO/2023/241927A1 |
A process for recovering an amine substance from a polyurethane material, preferably from an end-of-life (eol) polyurethane material, is provided, wherein the process comprises alcoholising a polyurethane material by contacting the polyu...
|
|
WO/2023/240629A1 |
Provided are an ionic compound and a use thereof, a perovskite precursor solution, a perovskite material, a solar material, a solar cell, and an electrical device. The structure of the ionic compound is as shown in any one of formulas (1...
|
|
WO/2023/239092A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2023/239091A1 |
The present invention provides a novel compound and an organic light-emitting device using same.
|
|
WO/2023/237073A1 |
The present invention relates to an organic compound comprising an aromatic amine, and the use thereof in an organic electronic device. The organic compound according to the present invention has a relatively high thermal stability, wher...
|
|
WO/2023/238137A1 |
One or more ionizable lipid(s) and lipid nanoparticles comprising same are provided. Pharmaceutical compositions comprising the lipid nanoparticles encapsulating an active agent are also provided.
|
|
WO/2023/230649A1 |
The present disclosure relates to compounds of formula (I), their methods of synthesis, and their use in the treatment of mental illness or central nervous system disorders.
|
|
WO/2023/229295A1 |
The present invention relates to a phenylpropene derivative, and a pharmaceutical composition for the prevention or treatment of cancer, comprising the phenylpropene derivative as an active ingredient. The phenylpropene derivative disclo...
|
|
WO/2023/227996A1 |
The present invention relates to a process for synthesis of a deuterated compound. Most particularly, it relates to synthesis of a deuterated amine compounds of formula (l) and salts thereof. The said compound is an important key interme...
|
|
WO/2023/224020A1 |
Provided is a compound represented by formula (1). (The symbols in formula (1) are as defined in the specification.) Also provided are an organic electroluminescent element that contains the compound and an electronic device that include...
|
|
WO/2023/224418A1 |
The present invention relates to a method for producing, from fatty alcohols, various monomers that are used in the production of synthetic resins.
|
|
WO/2023/222559A1 |
The present invention relates to a process for preparing a deuterated organic compound, comprising the following steps: preparing a liquid composition comprising the organic compound, at least one heterogeneous metal catalyst, at least o...
|
|
WO/2023/221231A1 |
The present invention relates to an aromatic amine compound containing a quaterphenyl structure and an organic electroluminescent device. The aromatic amine compound serves as a hole transport layer and/or a light-emitting auxiliary laye...
|
|
WO/2023/221981A1 |
Taxamairin and analogs thereof useful in the treatment of inflammatory diseases or conditions, such as inflammatory bowel disease, pharmaceutical compositions including the same, and methods of use and preparation thereof.
|
|
WO/2023/216458A1 |
Provided is a production process for hydrogenation of o-phenylenediamine, comprising the following steps: adding a porous catalyst to an autoclave, adding o-nitroaniline and methanol in sequence, introducing hydrogen to replace the air i...
|
|
WO/2023/216168A1 |
The present application discloses a pore-forming agent, comprising a central ion, an acid radical ion, and a ligand molecule. The central ion is a lithium ion. The ligand molecule has a structure represented by formula I, wherein R1 and ...
|
|
WO/2022/256236A9 |
A compound having Formula (I) or Formula (II) or a mixture thereof, in which R is H; CH3; CH-(CH3)2; CH2-CH-(CH3)2; CH-(CH3)-CH2-CH3; CH2-(C6H5); CH2-(3-indole); CH2-CH2-S-CH3; CH2-OH; CH-(CH3)-OH; CH2-SH; CH2-(p-C6H4OH); CH2-CH2-CH2-CH2...
|
|
WO/2023/207102A1 |
A lipid nanoparticle is provided, wherein the lipid ingredient comprises a compound of formula (IV). A method of preparing the lipid nanoparticle, a pharmaceutical composition of the lipid nanoparticle, and use of the lipid nanoparticle ...
|
